Next Article in Journal
Renal Dopamine Receptors, Oxidative Stress, and Hypertension
Previous Article in Journal
Cytogenetic Abnormalities in Lymphocytes from Victims Exposed to Cobalt-60 Radiation
Int. J. Mol. Sci. 2013, 14(9), 17536-17552; doi:10.3390/ijms140917536
Article

Assessment of Blood Flow in Hepatocellular Carcinoma: Correlations of Computed Tomography Perfusion Imaging and Circulating Angiogenic Factors

1,2
, 3,4,5
, 5,6
, 3
, 3,5
 and 3,5,7,*
Received: 3 June 2013; in revised form: 22 July 2013 / Accepted: 15 August 2013 / Published: 27 August 2013
View Full-Text   |   Download PDF [2285 KB, uploaded 19 June 2014]   |   Browse Figures
Abstract: Hepatocellular carcinoma (HCC) is a highly vascular tumor through the process of angiogenesis. To evaluate more non-invasive techniques for assessment of blood flow (BF) in HCC, this study examined the relationships between BF of HCC measured by computer tomography (CT) perfusion imaging and four circulating angiogenic factors in HCC patients. Interleukin 6 (IL-6), interleukin 8 (IL-8), vascular endothelial growth factor (VEGF), and platelet derived growth factor (PDGF) in plasma were measured using Bio-Plex multiplex immunoassay in 21 HCC patients and eight healthy controls. Circulating IL-6, IL-8 and VEGF showed higher concentrations in HCC patients than in controls (p < 0.05), and predicted HCC occurrence better than chance (p < 0.01). Twenty-one patients with HCC received 21-phase liver imaging using a 64-slice CT. Total BF, arterial BF, portal BF, arterial fraction (arterial BF/total BF) of the HCC and surrounding liver parenchyma, and HCC-parenchyma ratio were measured using a dual-vessel model. After analyzing the correlations between BF in HCC and four circulating angiogenic factors, we found that the HCC-parenchyma ratio of arterial BF showed a significantly positive correlation with the level of circulating IL-8 (p < 0.05). This circulating biomarker, IL-8, provides a non-invasive tool for assessment of BF in HCC.
Keywords: hepatocellular carcinoma; blood flow; circulating angiogenic factors; CT perfusion; interleukin 8 hepatocellular carcinoma; blood flow; circulating angiogenic factors; CT perfusion; interleukin 8
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Chen, Y.-W.; Pan, H.-B.; Tseng, H.-H.; Hung, Y.-T.; Huang, J.-S.; Chou, C.-P. Assessment of Blood Flow in Hepatocellular Carcinoma: Correlations of Computed Tomography Perfusion Imaging and Circulating Angiogenic Factors. Int. J. Mol. Sci. 2013, 14, 17536-17552.

AMA Style

Chen Y-W, Pan H-B, Tseng H-H, Hung Y-T, Huang J-S, Chou C-P. Assessment of Blood Flow in Hepatocellular Carcinoma: Correlations of Computed Tomography Perfusion Imaging and Circulating Angiogenic Factors. International Journal of Molecular Sciences. 2013; 14(9):17536-17552.

Chicago/Turabian Style

Chen, Ya-Wen; Pan, Huay-Ben; Tseng, Hui-Hwa; Hung, Yu-Ting; Huang, Jer-Shyung; Chou, Chen-Pin. 2013. "Assessment of Blood Flow in Hepatocellular Carcinoma: Correlations of Computed Tomography Perfusion Imaging and Circulating Angiogenic Factors." Int. J. Mol. Sci. 14, no. 9: 17536-17552.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert